메뉴 건너뛰기




Volumn 44, Issue 2, 1999, Pages 156-162

Expression of Fas ligand by human gastric adenocarcinomas: A potential mechanism of immune escape in stomach cancer

Author keywords

Apoptosis; Fas ligand; Gastric cancer; Immune escape; mRNA; Tumour

Indexed keywords

FAS LIGAND;

EID: 0033059651     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.2.156     Document Type: Article
Times cited : (121)

References (33)
  • 1
    • 0028829525 scopus 로고
    • The expression of tumor-rejection antigen "MAGE" genes in human gastric carcinoma
    • Inoue H, Mori M, Honda M, et al. The expression of tumor-rejection antigen "MAGE" genes in human gastric carcinoma. Gastroenterology 1995;109:1522-5.
    • (1995) Gastroenterology , vol.109 , pp. 1522-1525
    • Inoue, H.1    Mori, M.2    Honda, M.3
  • 2
    • 0030887192 scopus 로고    scopus 로고
    • HLA class-I-restricted and tumor-specific CTL in tumor-infiltrating lymphocytes of patients with gastric cancer
    • Hoshino T, Seki N, Kikuchi M, et al. HLA class-I-restricted and tumor-specific CTL in tumor-infiltrating lymphocytes of patients with gastric cancer. Int J Cancer 1997;70:631-8.
    • (1997) Int J Cancer , vol.70 , pp. 631-638
    • Hoshino, T.1    Seki, N.2    Kikuchi, M.3
  • 3
    • 0030972184 scopus 로고    scopus 로고
    • Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer
    • Maehara Y, Tomisaki S, Oda S, et al. Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer. Int J Cancer 1997;74:224-8.
    • (1997) Int J Cancer , vol.74 , pp. 224-228
    • Maehara, Y.1    Tomisaki, S.2    Oda, S.3
  • 4
    • 0028927607 scopus 로고
    • The Fas death factor
    • Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-56.
    • (1995) Science , vol.267 , pp. 1449-1456
    • Nagata, S.1    Golstein, P.2
  • 5
    • 0028092366 scopus 로고
    • Apoptosis defects analyzed in TcR transgenic and fas transgenic lpr mice
    • Mountz JD, Zhou T, Bluethmann H, et al. Apoptosis defects analyzed in TcR transgenic and fas transgenic lpr mice. Int Rev Immunol 1994;11:321-42.
    • (1994) Int Rev Immunol , vol.11 , pp. 321-342
    • Mountz, J.D.1    Zhou, T.2    Bluethmann, H.3
  • 6
    • 0028909197 scopus 로고
    • Fas ligand mediates activation-induced cell death in human T lymphocytes
    • Alderson MR, Tough TW, Davis-Smith T, et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995;181:71-7.
    • (1995) J Exp Med , vol.181 , pp. 71-77
    • Alderson, M.R.1    Tough, T.W.2    Davis-Smith, T.3
  • 7
    • 0028238410 scopus 로고
    • Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells
    • Daniel PT, Krammer PH. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J Immunol 1994;152:5624-32.
    • (1994) J Immunol , vol.152 , pp. 5624-5632
    • Daniel, P.T.1    Krammer, P.H.2
  • 8
    • 0028879109 scopus 로고
    • Fas ligand-induced apoptosis as a mechanism of immune privilege
    • Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-92.
    • (1995) Science , vol.270 , pp. 1189-1192
    • Griffith, T.S.1    Brunner, T.2    Fletcher, S.M.3
  • 9
    • 0028864778 scopus 로고
    • A role for CD95 ligand in preventing graft rejection
    • Bellgrau D, Gold D, Selawry H, et al. A role for CD95 ligand in preventing graft rejection. Nature 1995;377:630-2.
    • (1995) Nature , vol.377 , pp. 630-632
    • Bellgrau, D.1    Gold, D.2    Selawry, H.3
  • 10
    • 0030821649 scopus 로고    scopus 로고
    • CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival
    • Stuart PM, Griffith TS, Usui N, et al. CD95 ligand (FasL)- induced apoptosis is necessary for corneal allograft survival. J Clin Invest 1997;99:396-402.
    • (1997) J Clin Invest , vol.99 , pp. 396-402
    • Stuart, P.M.1    Griffith, T.S.2    Usui, N.3
  • 11
    • 0030903088 scopus 로고    scopus 로고
    • Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immuno-suppression
    • Korbutt GS, Elliott JF, Rajotte RV. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 1997;46:317-22.
    • (1997) Diabetes , vol.46 , pp. 317-322
    • Korbutt, G.S.1    Elliott, J.F.2    Rajotte, R.V.3
  • 12
    • 0030017476 scopus 로고    scopus 로고
    • Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice
    • Lau HT, Yu M, Fontana A, et al. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 1996;270:109-12.
    • (1996) Science , vol.270 , pp. 109-112
    • Lau, H.T.1    Yu, M.2    Fontana, A.3
  • 13
    • 0030857077 scopus 로고    scopus 로고
    • Inhibition of the alloantibody response by CD95 ligand
    • Arai H, Chan SY, Bishop DK, et al. Inhibition of the alloantibody response by CD95 ligand. Nat Med 1997;3:843-8.
    • (1997) Nat Med , vol.3 , pp. 843-848
    • Arai, H.1    Chan, S.Y.2    Bishop, D.K.3
  • 14
    • 0029808372 scopus 로고    scopus 로고
    • The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
    • O'Connell J, O'Sullivan GC, Collins JK, et al. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996;184:1075-82.
    • (1996) J Exp Med , vol.184 , pp. 1075-1082
    • O'Connell, J.1    O'Sullivan, G.C.2    Collins, J.K.3
  • 15
    • 10544232277 scopus 로고    scopus 로고
    • Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape
    • Hahne M, Rimoldi D, Schroter M, et al. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 1996;274:1363-6.
    • (1996) Science , vol.274 , pp. 1363-1366
    • Hahne, M.1    Rimoldi, D.2    Schroter, M.3
  • 16
    • 16144363507 scopus 로고    scopus 로고
    • Lymphocyte apoptosis induced by CD95 (Apo-1/Fas) ligand-expressing tumor cells: A mechanism of immune evasion?
    • Strand S, Hofmann WJ, Hug H, et al. Lymphocyte apoptosis induced by CD95 (Apo-1/Fas) ligand-expressing tumor cells: a mechanism of immune evasion? Nat Med 1996;2:1361-6.
    • (1996) Nat Med , vol.2 , pp. 1361-1366
    • Strand, S.1    Hofmann, W.J.2    Hug, H.3
  • 17
    • 0030933337 scopus 로고    scopus 로고
    • Human lung carcinomas express Fas ligand
    • Niehans GA, Brunner T, Frizelle SP, et al. Human lung carcinomas express Fas ligand. Cancer Res 1997;57:1007-12.
    • (1997) Cancer Res , vol.57 , pp. 1007-1012
    • Niehans, G.A.1    Brunner, T.2    Frizelle, S.P.3
  • 18
    • 0030895084 scopus 로고    scopus 로고
    • Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain?
    • Saas P, Walker PR, Hahne M, et al. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J Clin Invest 1997;99:1173-8.
    • (1997) J Clin Invest , vol.99 , pp. 1173-1178
    • Saas, P.1    Walker, P.R.2    Hahne, M.3
  • 19
    • 0030960010 scopus 로고    scopus 로고
    • Expression of Fas ligand in liver metastases of human colonic adenocarcinomas
    • Shiraki K, Tsuji N, Shioda T, et al. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas. Proc Natl Acad Sci USA 1997;94:6420-5.
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 6420-6425
    • Shiraki, K.1    Tsuji, N.2    Shioda, T.3
  • 20
    • 0032103027 scopus 로고    scopus 로고
    • FasL expression in oesophageal carcinoma is associated with depletion of tumor infiltrating lymphocytes
    • Bennett MW, O'Connell J, O'Sullivan GC, et al. FasL expression in oesophageal carcinoma is associated with depletion of tumor infiltrating lymphocytes. J Immunol 1998;160:5669-75.
    • (1998) J Immunol , vol.160 , pp. 5669-5675
    • Bennett, M.W.1    O'Connell, J.2    O'Sullivan, G.C.3
  • 21
    • 0028783367 scopus 로고
    • Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
    • Galle PR, Hofmann WJ, Walczak H, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-30.
    • (1995) J Exp Med , vol.182 , pp. 1223-1230
    • Galle, P.R.1    Hofmann, W.J.2    Walczak, H.3
  • 22
    • 0028919473 scopus 로고
    • Expression of the functional soluble form of human fas ligand in activated lymphocytes
    • Tanaka M, Suda T, Takahashi T, et al. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J 1995;14:1129-35.
    • (1995) EMBO J , vol.14 , pp. 1129-1135
    • Tanaka, M.1    Suda, T.2    Takahashi, T.3
  • 23
    • 0030850696 scopus 로고    scopus 로고
    • The Fas counterattack: A molecular mechanism of tumor immune privilege
    • O'Connell J, Bennett MW, O'Sullivan GC, et al. The Fas counterattack: a molecular mechanism of tumor immune privilege. Mol Med 1997;3:294-300.
    • (1997) Mol Med , vol.3 , pp. 294-300
    • O'Connell, J.1    Bennett, M.W.2    O'Sullivan, G.C.3
  • 24
    • 0031132872 scopus 로고    scopus 로고
    • Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus
    • Hunt JS, Vassmer D, Ferguson TA, et al. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J Immunol 1997;158:4122-8.
    • (1997) J Immunol , vol.158 , pp. 4122-4128
    • Hunt, J.S.1    Vassmer, D.2    Ferguson, T.A.3
  • 25
    • 0030584826 scopus 로고    scopus 로고
    • Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis
    • Eischen CM, Schilling JD, Lynch DH, et al. Fc receptor-injuced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J Immunol 1996;156:2693-9.
    • (1996) J Immunol , vol.156 , pp. 2693-2699
    • Eischen, C.M.1    Schilling, J.D.2    Lynch, D.H.3
  • 26
    • 0029788696 scopus 로고    scopus 로고
    • Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils
    • Liles WC, Kiener PA, Ledbetter JA, et al. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med 1996;184:429-40.
    • (1996) J Exp Med , vol.184 , pp. 429-440
    • Liles, W.C.1    Kiener, P.A.2    Ledbetter, J.A.3
  • 27
    • 0030972396 scopus 로고    scopus 로고
    • Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allograft
    • Allison J, Georgiou HM, Strasser A, et al. Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allograft. Proc Natl Acad Sci USA 1997;94:3943-7.
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 3943-3947
    • Allison, J.1    Georgiou, H.M.2    Strasser, A.3
  • 28
    • 0030842535 scopus 로고    scopus 로고
    • Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction
    • Kang S-M, Schneider DB, Lin Z, et al. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med 1997;3:738-43.
    • (1997) Nat Med , vol.3 , pp. 738-743
    • Kang, S.-M.1    Schneider, D.B.2    Lin, Z.3
  • 29
    • 0031042972 scopus 로고    scopus 로고
    • Antitumor effect of locally produced CD95 ligand
    • Seino K, Kayagaki N, Okumura K, et al. Antitumor effect of locally produced CD95 ligand. Nat Med 1997;3:165-70.
    • (1997) Nat Med , vol.3 , pp. 165-170
    • Seino, K.1    Kayagaki, N.2    Okumura, K.3
  • 30
    • 0031472398 scopus 로고    scopus 로고
    • Gene transfer of Fas ligand induces tumor regression in vivo
    • Arai H, Gordon D, Nabel EG, et al. Gene transfer of Fas ligand induces tumor regression in vivo. Proc Natl Acad Sci USA 1997;94:13862-7.
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 13862-13867
    • Arai, H.1    Gordon, D.2    Nabel, E.G.3
  • 31
    • 0030755435 scopus 로고    scopus 로고
    • FasL: Too much of a good thing?
    • Lau HT, Stoeckert CJ. FasL: too much of a good thing? Nat Med 1997;3:727-8.
    • (1997) Nat Med , vol.3 , pp. 727-728
    • Lau, H.T.1    Stoeckert, C.J.2
  • 32
    • 0030853159 scopus 로고    scopus 로고
    • Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer
    • Zhang H, Yang Y, Horton JL, et al. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J Clin Invest 1997;100:1951-7.
    • (1997) J Clin Invest , vol.100 , pp. 1951-1957
    • Zhang, H.1    Yang, Y.2    Horton, J.L.3
  • 33
    • 0021917804 scopus 로고
    • Lymphokine-activated killer (LAK) cells: Analysis of factors relevant to the immunotherapy of human cancer
    • Rayner AA, Grimm EA, Lotze MT. Lymphokine-activated killer (LAK) cells: analysis of factors relevant to the immunotherapy of human cancer. Cancer 1985;55:1327.
    • (1985) Cancer , vol.55 , pp. 1327
    • Rayner, A.A.1    Grimm, E.A.2    Lotze, M.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.